Interleukin-17 Signalling in Breast Cancer: Molecular Mechanisms and  Therapeutic Prospects

Reem Saeed El Yamany , Amal S. El-Shal, Eman H. Abdelbary, Mohamed I. Abdelhamid, Rasha Haggag ,  Walaa M Sarhan

Interleukin-17 Signalling in Breast Cancer: Molecular Mechanisms and Therapeutic Prospects

Authors

Reem Saeed El Yamany , Amal S. El-Shal, Eman H. Abdelbary, Mohamed I. Abdelhamid, Rasha Haggag , Walaa M Sarhan

Keywords:

Interleukin-17, Breast Cancer, Molecular Mechanisms

Abstract

Background: Breast cancer remains the most commonly diagnosed malignancy among women and a leadingcause of cancer-related mortality worldwide. Increasing evidence highlights the importance of immune-mediatedinflammation as a driver of breast carcinogenesis, tumor progression, and therapeutic resistance. Among inflammatory cytokines

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424

Downloads

Published

2024-05-20

How to Cite

Reem Saeed El Yamany , Amal S. El-Shal, Eman H. Abdelbary, Mohamed I. Abdelhamid, Rasha Haggag , Walaa M Sarhan. (2024). Interleukin-17 Signalling in Breast Cancer: Molecular Mechanisms and Therapeutic Prospects . Journal of Computational Analysis and Applications (JoCAAA), 33(06), 3751–3765. Retrieved from https://www.eudoxuspress.com/index.php/pub/article/view/4486